Medopharm Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
- Paid Up Capital ₹ 22.00 Cr
- Company Age 44 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 304.98 Cr
- Satisfied Charges ₹ 31.02 Cr
- Revenue Growth 35.66%
- Profit Growth 272.51%
- Ebitda 17.79%
- Net Worth 4.97%
- Total Assets 2.73%
About Medopharm
Medopharm Private Limited (MPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 31 March 1980 and has a history of 44 years and ten months. Its registered office is in Chennai, Tamil Nadu, India.
The Corporate was formerly known as Medopharm Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 30.00 Cr and a paid-up capital of Rs 22.00 Cr.
The company currently has active open charges totaling ₹304.98 Cr. The company has closed loans amounting to ₹31.02 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Medopharm Private Limited India is Shoban Babu as COMPANY SECRETARY.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U15100TN1980PTC008206
-
Company No.
008206
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
31 Mar 1980
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Medopharm?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shoban Babu | Company Secretary | Current | |
Udhan Chordia | Managing Director | 10-Aug-2020 | Current |
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Pannalal Chordia | Director | 10-Aug-2020 | Current |
Surendar Chordia | Director | 10-Aug-2020 | Current |
Mohanmull Chordia | Director | 14-Dec-2004 | Current |
Gambhir Chordia | Director | 10-Aug-2020 | Current |
Financial Performance of Medopharm.
Medopharm Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 35.66% increase. The company also saw a substantial improvement in profitability, with a 272.51% increase in profit. The company's net worth moved up by a moderate rise of 4.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Medopharm?
In 2023, Medopharm had a promoter holding of 100.00%. The company had 1 Subsidiary, 1 Joint Venture and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹304.98 Cr
₹31.02 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 160.00 Cr
- Others : 143.09 Cr
- Yes Bank Limited : 1.89 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
29 Aug 2023 | Yes Bank Limited | ₹1.89 Cr | Open |
22 Jul 2021 | Others | ₹0.90 M | Open |
17 Apr 2021 | Hdfc Bank Limited | ₹10.05 Cr | Open |
03 Nov 2015 | Hdfc Bank Limited | ₹37.95 Cr | Open |
24 Mar 2015 | Others | ₹46.50 Cr | Open |
How Many Employees Work at Medopharm?
Medopharm has a workforce of 442 employees as of Apr 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medopharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medopharm's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.